30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Healthcare Sector Insider Trading Activity

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 3,186 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière (USDm) # acheteurs nets Valeur nette ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals & Medical Research Mega (1.0tn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (570.5bn) -1–5 -$1M–$10M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (381.1bn) 0 Aucune activité — 0–15%
Healthcare Services Mega (369.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (326.2bn) 0 Aucune activité — —
Pharmaceuticals & Medical Research Mega (290.1bn) -1–5 -$1M–$10M -0–15% 0–15%
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (287.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (269.7bn) 0 Aucune activité — 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Large (179.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (167.0bn) 0 Aucune activité — 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Large (164.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (155.9bn) 0 Aucune activité — 0–15%
Healthcare Services Large (154.2bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (150.4bn) 0 Aucune activité — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (146.5bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Large (128.2bn) -1–5 -$100M+ -0–15% 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (120.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (116.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (115.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (112.9bn) 0 Aucune activité — 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (107.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (107.4bn) 0 Aucune activité — 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (101.7bn) 11–20 $100K–$1M 0–15% 0–15%
Healthcare Services Large (97.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (96.7bn) 0 Aucune activité — 15–50%
Healthcare Services Large (90.8bn) -1–5 -$100K–$1M -0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 Aucune activité — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 Aucune activité — —
Pharmaceuticals & Medical Research Large (73.5bn) 0 Aucune activité — 0–15%
Healthcare Services Large (72.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (67.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (65.3bn) -1–5 -$100M+ -15–50% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 Aucune activité — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (59.7bn) 0 Aucune activité — 15–50%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (57.8bn) -1–5 -$1M–$10M -0–15% —
US Cencora Inc (COR)
Healthcare Services Large (54.7bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (50.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US Humana Inc (HUM)
Healthcare Services Large (45.5bn) 0 Aucune activité — 0–15%
Healthcare Services Large (44.7bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Large (43.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 Aucune activité — 0–15%
Healthcare Services Large (43.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (42.4bn) 0 Aucune activité — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (41.8bn) 1–5 $1M–$10M 0–15% —
Pharmaceuticals & Medical Research Large (40.1bn) 0 Aucune activité — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (40.1bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Large (39.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (39.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (38.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (37.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (35.3bn) 0 Aucune activité — 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (34.1bn) 1–5 $100K–$1M 0–15% 0–15%
US Waters Corp (WAT)
Healthcare Services Large (32.9bn) 0 Aucune activité — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (32.1bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 Aucune activité — 50%+
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (30.5bn) 0 Aucune activité — 0–15%
Healthcare Services Large (29.9bn) 0 Aucune activité — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (29.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (29.1bn) 1–5 $10M–$100M 50%+ 15–50%
US DexCom Inc (DXCM)
Healthcare Services Large (28.2bn) 0 Aucune activité — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 Aucune activité — 0–15%
Healthcare Services Large (27.8bn) 6–10 $1M–$10M 0–15% 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (27.0bn) 0 Aucune activité — 0–15%
Healthcare Services Large (26.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (26.6bn) 0 Aucune activité — 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (25.0bn) -1–5 -$100M+ -0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (24.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (23.9bn) -1–5 -$10M–$100M -0–15% 15–50%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 Aucune activité — 0–15%
Healthcare Services Large (23.8bn) -1–5 -$1M–$10M -0–15% 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.3bn) -1–5 -$1M–$10M -0–15% 50%+
Healthcare Services Large (23.2bn) 1–5 $1M–$10M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (21.7bn) 0 Aucune activité — 0–15%
Healthcare Services Large (21.4bn) 0 Aucune activité — 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (21.4bn) -1–5 -$1M–$10M -0–15% 0–15%
IE STERIS plc (STE)
Healthcare Services Large (20.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 Aucune activité — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (19.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (18.9bn) -1–5 -$1M–$10M -0–15% 50%+
Healthcare Services Large (18.9bn) 1–5 $100K–$1M 0–15% 15–50%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.1bn) 0 Aucune activité — 0–15%
Healthcare Services Large (17.9bn) 0 Aucune activité — 50%+
Healthcare Services Large (17.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (17.3bn) -11–20 -$10M–$100M -0–15% 0–15%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 Aucune activité — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (16.6bn) -6–10 -$1M–$10M -0–15% 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (16.5bn) 0 Aucune activité — —
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (15.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (15.7bn) 0 Aucune activité — 50%+
Healthcare Services Large (15.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (15.1bn) -1–5 -$1M–$10M -0–15% 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (15.0bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Large (14.8bn) 1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (14.1bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (14.0bn) 0 Aucune activité — 0–15%